IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
0.780
-0.040 (-4.94%)
Nov 21, 2024, 11:37 AM EST - Market open

IO Biotech Statistics

Total Valuation

IO Biotech has a market cap or net worth of $51.39 million. The enterprise value is -$24.10 million.

Market Cap 51.39M
Enterprise Value -24.10M

Important Dates

The last earnings date was Tuesday, November 12, 2024, before market open.

Earnings Date Nov 12, 2024
Ex-Dividend Date n/a

Share Statistics

IO Biotech has 65.88 million shares outstanding. The number of shares has increased by 92.75% in one year.

Current Share Class 65.88M
Shares Outstanding 65.88M
Shares Change (YoY) +92.75%
Shares Change (QoQ) n/a
Owned by Insiders (%) 0.23%
Owned by Institutions (%) 18.53%
Float 27.84M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.75
P/TBV Ratio 0.75
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.37, with a Debt / Equity ratio of 0.03.

Current Ratio 5.37
Quick Ratio 5.05
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -78.50% and return on invested capital (ROIC) is -51.33%.

Return on Equity (ROE) -78.50%
Return on Assets (ROA) -45.91%
Return on Capital (ROIC) -51.33%
Revenue Per Employee n/a
Profits Per Employee -$1.33M
Employee Count 68
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, IO Biotech has paid $1.35 million in taxes.

Income Tax 1.35M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -17.47% in the last 52 weeks. The beta is 0.42, so IO Biotech's price volatility has been lower than the market average.

Beta (5Y) 0.42
52-Week Price Change -17.47%
50-Day Moving Average 1.09
200-Day Moving Average 1.35
Relative Strength Index (RSI) 32.75
Average Volume (20 Days) 324,571

Short Selling Information

The latest short interest is 200,923, so 0.30% of the outstanding shares have been sold short.

Short Interest 200,923
Short Previous Month 277,050
Short % of Shares Out 0.30%
Short % of Float 0.72%
Short Ratio (days to cover) 1.89

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -96.42M
Pretax Income -87.64M
Net Income -90.34M
EBITDA -96.17M
EBIT -96.42M
Earnings Per Share (EPS) -$1.37
Full Income Statement

Balance Sheet

The company has $80.19 million in cash and $2.02 million in debt, giving a net cash position of $78.17 million or $1.19 per share.

Cash & Cash Equivalents 80.19M
Total Debt 2.02M
Net Cash 78.17M
Net Cash Per Share $1.19
Equity (Book Value) 72.57M
Book Value Per Share 1.10
Working Capital 70.19M
Full Balance Sheet

Cash Flow

Operating Cash Flow -85.52M
Capital Expenditures -145,000
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

IO Biotech does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -92.75%
Shareholder Yield -92.75%
Earnings Yield -167.10%
FCF Yield n/a

Analyst Forecast

The average price target for IO Biotech is $9.33, which is 1,096.15% higher than the current price. The consensus rating is "Strong Buy".

Price Target $9.33
Price Target Difference 1,096.15%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -28.20%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1